Insider trades
EcoR1 Capital, 10% Owner of Atara Biotherapeutics ATRA, has filed 60 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $20.2M. The latest trade was on 05/07.
EcoR1 Capital
10% Owner
- Company
- Atara Biotherapeutics ATRA
- First filing
- 23/01/18
- Trades
- 91 trades
- Buys / sales
- 60 / 13
- 12-month net buying
- −$20.2M
- Last trade
- 05/07
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 05/07 | 05/11 | 507,407 sh | $9.35 | $4,744,255.45 | +48.6% | |
| Open-market sale | 04/20 | 04/22 | 4,705,575 sh | $13.81 | $64,983,990.75 | No record | |
AKTS | Open-market buy | 01/12 | 01/12 | 2,222,222 sh2 trades | $18.00avg. | $39,999,996 | No record |
ADAPY | Open-market sale | 25/07/28–25/07/30 | 25/07/30 | 64,052,538 sh3 trades | $0.11avg. | $6,744,571.2 | −39.0% |
ZYME | Open-market buy | 25/05/15–25/05/19 | 25/05/19 | 55,421 sh2 trades | $11.47avg. | $635,533.68 | +0.3% |
| Open-market buy | 25/05/14–25/05/15 | 25/05/16 | 4,958,978 sh2 trades | $7.80avg. | $38,693,026.98 | +86.5% | |
PRTA | Open-market sale | 25/05/02–25/05/06 | 25/05/06 | 6,279,684 sh3 trades | $8.09avg. | $50,825,216.83 | −54.2% |
ZYME | Open-market buy | 25/04/16–25/04/17 | 25/04/18 | 128,713 sh2 trades | $11.31avg. | $1,456,150.68 | +0.7% |
ZYME | Open-market buy | 25/04/03–25/04/04 | 25/04/07 | 317,208 sh2 trades | $11.43avg. | $3,624,129.26 | +1.8% |
ZYME | Open-market buy | 25/03/31–25/04/02 | 25/04/02 | 127,415 sh3 trades | $11.75avg. | $1,497,263.55 | +0.7% |
ZYME | Open-market buy | 25/03/25–25/03/26 | 25/03/27 | 97,349 sh2 trades | $12.61avg. | $1,227,397.43 | +0.6% |
ZYME | Open-market buy | 25/03/20–25/03/24 | 25/03/24 | 127,198 sh3 trades | $12.92avg. | $1,643,418.54 | +0.7% |
ZYME | Open-market buy | 25/03/17–25/03/19 | 25/03/19 | 228,463 sh3 trades | $12.54avg. | $2,865,837.55 | +1.4% |
ZYME | Open-market buy | 25/03/11–25/03/13 | 25/03/13 | 1,081,980 sh3 trades | $12.12avg. | $13,118,252.48 | +6.9% |
ZYME | Open-market buy | 25/01/16–25/01/17 | 25/01/21 | 141,429 sh2 trades | $13.89avg. | $1,964,053.85 | +0.9% |
ZYME | Open-market buy | 25/01/13–25/01/15 | 25/01/15 | 167,654 sh3 trades | $13.59avg. | $2,278,350.04 | +1.1% |
ZYME | Open-market buy | 25/01/08–25/01/10 | 25/01/10 | 225,119 sh2 trades | $13.22avg. | $2,975,572.21 | +1.5% |
ANAB | Open-market buy | 24/12/30–25/01/02 | 25/01/02 | 85,098 sh3 trades | $12.92avg. | $1,099,798.22 | +1.1% |
ZYME | Open-market buy | 24/12/30–25/01/02 | 25/01/02 | 363,369 sh3 trades | $14.65avg. | $5,321,542.33 | +2.5% |
ZYME | Open-market buy | 24/12/24–24/12/27 | 24/12/27 | 130,309 sh3 trades | $14.44avg. | $1,881,916.83 | +0.9% |
